HCMC — Vietnam’s Genfarma JSC has received technology from Cuba to produce pharmaceuticals locally, aiming to boost domestic research and drug manufacturing capacity.
During a visit to Genfarma’s plant on August 31, Cuban President Miguel Díaz-Canel said Cuba’s biotechnology sector has achieved significant progress, and that the technology transfer would benefit both countries and support the production of essential drugs.
Vietnam’s Health Minister Dao Hong Lan said the project is the outcome of an agreement reached during Party General Secretary To Lam’s visit to Cuba in September 2024. She noted the transfer will help Vietnam access advanced manufacturing technologies and reduce reliance on imports, particularly for biologics and biotechnology products.
The project is expected to improve access to quality medicines at affordable prices, including for cancer treatments.
The collaboration follows a joint venture agreement signed in May between BioCubaFarma SA, Cuba’s national pharmaceutical group, and Vietnamese companies. Within three months, the project established facilities for production.
BioCubaFarma operates 51 subsidiaries and nine joint ventures abroad, including six with production facilities. The company exports more than 300 products to over 40 countries and has transferred technology to Brazil, India, Venezuela, Algeria, China, Russia, Iran, and other markets.
